Construction of Hybrid Artificial Liver with Immortalized Human Hepatocytes
永生化人肝细胞混合人工肝的构建
基本信息
- 批准号:09671254
- 负责人:
- 金额:$ 1.98万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (C)
- 财政年份:1997
- 资助国家:日本
- 起止时间:1997 至 1999
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Use of primary culture of hepatocytes in developing hybrid artificial liver is a topic of active research. However, primary cultures of hepatocytes remain viable for only a few weeks under normal cultivation conditions. By using adenovirus vector and introducing SV40 primary gene into rat and marmoset primary cultures of hepatocytes. I have succeeded in transformed conversion resulting in longer cultivation period, immortalization, and massive cultivation. By using the same technique, I have attempted to produce hybrid artificial liver by using human hepatocytes.Methods and Results: 1. Adenovirus vector produced by recombination of E1A and E1B genes in human adenovirus with multiple deletion SV40 primary genes, was added to human primary cultures of hepatocytes by MOI (multiplicity of infection) and cultivated under 37℃ for two hours, then fixed in ethanol after 48 hours of additional cultivation, and immunostained by using antibody to SV40T antigen. Rate of T antigen positive was appr … More oximately 20% in MOI 100, 4% in MOI 10, less than 0.5% in MOI 1, and these results were depend on MOI.2. Adenovirus vector was introduced in human hepatocytes in MOI 100 and plated to 1xl0ィイD16ィエD1 flask(25 cmィイD13ィエD1). After 3-4 weeks, approximately 100/colonies undergoing transformed conversion were produced from 10 cells.3. Human hepatocytes introducing with primary SV40 genes were cultivated as a bulk for longer than 12 months and the cells mostly SV40T antigen positive, continued to reproducefavorably and attained immortalization. Also immunostaining with albumin was localization in cytosol of these cells.Conclusion: By using adenovirus vector efficient introduction of SV40 primary gene and transformed conversion was possible resulting in massive cultivation and immortalization.Discussion: Under the single layer cultivation method employed this time, hepatocyte function was found to deterorated with time by measuring urea production and tyrosine amino transferase (TAT) activity. I plan to used third degree high dense cultivation to improve this aspect in the future. Less
利用原代肝细胞培养技术研制杂交型人工肝是目前研究的热点。然而,肝细胞的原代培养物在正常培养条件下仅能存活数周。利用腺病毒载体,将SV 40原代基因导入大鼠和绒猴原代培养的肝细胞中。我已经成功蜕变,修炼时间更长,长生化,大规模修炼。利用同样的技术,我尝试了利用人肝细胞制备杂交型人工肝。将E1 A和E1 B基因重组于人腺病毒中并与多个缺失的SV 40一级基因重组产生的腺病毒载体,通过MOI(感染复数)加入人肝细胞原代培养物中,在37℃下培养2小时,然后在额外培养48小时后在乙醇中固定,并通过使用抗SV 40 T抗原的抗体进行免疫染色。T抗原阳性率约为 ...更多信息 MOI 100时氧化苦参碱含量为20%,MOI 10时氧化苦参碱含量为4%,MOI 1时氧化苦参碱含量小于0.5%,且氧化苦参碱含量与MOI有关。将腺病毒载体以MOI 100引入人肝细胞中,并接种到1 × 105 × D16 × D13 × D1烧瓶(25 cm × D13 × D13 × D1)中。3-4周后,从10个细胞产生约100个/菌落进行转化转化。将原代导入SV 40基因的人肝细胞培养12个月以上,细胞大多呈SV 40 T抗原阳性,并可持续增殖,达到永生化。结论:利用腺病毒载体有效地导入SV 40原代基因并转化,可实现大规模培养和永生化,并通过测定尿素生成和酪氨酸氨基转移酶(达特)活性,发现在单层培养方法下,肝细胞功能随时间的推移而下降。我打算以后用三度高密度培养来提高这方面。少
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KATAYAMA Tokitaka其他文献
KATAYAMA Tokitaka的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KATAYAMA Tokitaka', 18)}}的其他基金
Construction of Hybrid Artificial Liver with Immortalized Human Hepatocytes
永生化人肝细胞混合人工肝的构建
- 批准号:
07807117 - 财政年份:1995
- 资助金额:
$ 1.98万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Construction of Hybrid Artificial Liver with Immortalized Human Hepatocytes.
永生化人肝细胞混合人工肝的构建。
- 批准号:
05807109 - 财政年份:1993
- 资助金额:
$ 1.98万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
相似海外基金
Study into the effect of candidalysin exotoxin secretion and fungal ROS generation on C. albicans infection on human hepatocytes
念珠菌素外毒素分泌和真菌ROS生成对白色念珠菌感染人肝细胞影响的研究
- 批准号:
24K18435 - 财政年份:2024
- 资助金额:
$ 1.98万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Thyroid Hormone Signaling in Human Hepatocytes
人肝细胞中的甲状腺激素信号传导
- 批准号:
10874207 - 财政年份:2023
- 资助金额:
$ 1.98万 - 项目类别:
Promoting in vitro propagation of primary human hepatocytes as organoids using cues from natural liver regeneration
利用自然肝再生的线索促进原代人肝细胞作为类器官的体外增殖
- 批准号:
471981 - 财政年份:2022
- 资助金额:
$ 1.98万 - 项目类别:
Fellowship Programs
Reprogramming adult human hepatocytes into liver progenitors with unlimited self-renewal, efficient differentiation, and transplantation capacities
将成人肝细胞重编程为具有无限自我更新、高效分化和移植能力的肝祖细胞
- 批准号:
MR/V005537/1 - 财政年份:2020
- 资助金额:
$ 1.98万 - 项目类别:
Research Grant
Roles of human cytochrome P450 1A2, 2C9, and 3A4/5 enzymes in drug oxidations mediated by metabolically inactivated human hepatocytes in previously transplanted chimeric mice
人细胞色素 P450 1A2、2C9 和 3A4/5 酶在先前移植的嵌合小鼠中代谢失活的人肝细胞介导的药物氧化中的作用
- 批准号:
20K07164 - 财政年份:2020
- 资助金额:
$ 1.98万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Thyroid Hormone Signaling in Human Hepatocytes
人肝细胞中的甲状腺激素信号传导
- 批准号:
9902423 - 财政年份:2019
- 资助金额:
$ 1.98万 - 项目类别:
Thyroid Hormone Signaling in Human Hepatocytes
人肝细胞中的甲状腺激素信号传导
- 批准号:
10087920 - 财政年份:2019
- 资助金额:
$ 1.98万 - 项目类别:
Collaborative Research: Protein nanofiber growth factor delivery platforms for modulating phenotype of iPSC-derived human hepatocytes and liver non-parenchymal cells
合作研究:用于调节 iPSC 衍生的人肝细胞和肝脏非实质细胞表型的蛋白质纳米纤维生长因子递送平台
- 批准号:
1933552 - 财政年份:2019
- 资助金额:
$ 1.98万 - 项目类别:
Standard Grant